| Jeffrey E Harvan, CRNA | |
|
3300 Gallows Rd, Falls Church, VA 22042-3307 | |
| (703) 776-3138 | |
| Not Available |
| Full Name | Jeffrey E Harvan |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 23 Years |
| Location | 3300 Gallows Rd, Falls Church, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346288800 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 0001176758 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northstar Anesthesia Of Virginia, Llc | 6608268826 | 349 |
News Archive
Isotechnika Inc. has announced that the Company has been issued Norwegian Patent No. 324042 for its lead immunosuppressive drug, ISA247.
The primary targets of HIV-1 infection in the human vagina have been definitively identified in a new study published in the February 2007 issue of the journal Immunity. The findings are likely to guide development of new strategies that will prevent HIV-1 transmission.
When it comes to brain scans for assessing head trauma, detecting brain cancer, and performing numerous other tests, magnetic resonance imaging (MRI) is the best option, but MRI scanners are costly, require special infrastructure, and are immobile.
NovaBay Pharmaceuticals, Inc. announced today that the latest public data on its Aganocide® compounds, a new class of broad-spectrum antimicrobials, will be presented during three poster sessions at the Association for Research in Vision and Ophthalmology annual meeting in Fort Lauderdale, Florida.
› Verified 9 days ago
| Entity Name | American Anesthesiology Of Virginia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417994872 PECOS PAC ID: 6800790023 Enrollment ID: O20031120000429 |
News Archive
Isotechnika Inc. has announced that the Company has been issued Norwegian Patent No. 324042 for its lead immunosuppressive drug, ISA247.
The primary targets of HIV-1 infection in the human vagina have been definitively identified in a new study published in the February 2007 issue of the journal Immunity. The findings are likely to guide development of new strategies that will prevent HIV-1 transmission.
When it comes to brain scans for assessing head trauma, detecting brain cancer, and performing numerous other tests, magnetic resonance imaging (MRI) is the best option, but MRI scanners are costly, require special infrastructure, and are immobile.
NovaBay Pharmaceuticals, Inc. announced today that the latest public data on its Aganocide® compounds, a new class of broad-spectrum antimicrobials, will be presented during three poster sessions at the Association for Research in Vision and Ophthalmology annual meeting in Fort Lauderdale, Florida.
› Verified 9 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
Isotechnika Inc. has announced that the Company has been issued Norwegian Patent No. 324042 for its lead immunosuppressive drug, ISA247.
The primary targets of HIV-1 infection in the human vagina have been definitively identified in a new study published in the February 2007 issue of the journal Immunity. The findings are likely to guide development of new strategies that will prevent HIV-1 transmission.
When it comes to brain scans for assessing head trauma, detecting brain cancer, and performing numerous other tests, magnetic resonance imaging (MRI) is the best option, but MRI scanners are costly, require special infrastructure, and are immobile.
NovaBay Pharmaceuticals, Inc. announced today that the latest public data on its Aganocide® compounds, a new class of broad-spectrum antimicrobials, will be presented during three poster sessions at the Association for Research in Vision and Ophthalmology annual meeting in Fort Lauderdale, Florida.
› Verified 9 days ago
| Entity Name | Northstar Anesthesia Of Virginia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194488791 PECOS PAC ID: 6608268826 Enrollment ID: O20220120002585 |
News Archive
Isotechnika Inc. has announced that the Company has been issued Norwegian Patent No. 324042 for its lead immunosuppressive drug, ISA247.
The primary targets of HIV-1 infection in the human vagina have been definitively identified in a new study published in the February 2007 issue of the journal Immunity. The findings are likely to guide development of new strategies that will prevent HIV-1 transmission.
When it comes to brain scans for assessing head trauma, detecting brain cancer, and performing numerous other tests, magnetic resonance imaging (MRI) is the best option, but MRI scanners are costly, require special infrastructure, and are immobile.
NovaBay Pharmaceuticals, Inc. announced today that the latest public data on its Aganocide® compounds, a new class of broad-spectrum antimicrobials, will be presented during three poster sessions at the Association for Research in Vision and Ophthalmology annual meeting in Fort Lauderdale, Florida.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey E Harvan, CRNA 3100 Spring Forest Rd Ste 130, Raleigh, NC 27616-2880 Ph: (919) 882-7908 | Jeffrey E Harvan, CRNA 3300 Gallows Rd, Falls Church, VA 22042-3307 Ph: (703) 776-3138 |
News Archive
Isotechnika Inc. has announced that the Company has been issued Norwegian Patent No. 324042 for its lead immunosuppressive drug, ISA247.
The primary targets of HIV-1 infection in the human vagina have been definitively identified in a new study published in the February 2007 issue of the journal Immunity. The findings are likely to guide development of new strategies that will prevent HIV-1 transmission.
When it comes to brain scans for assessing head trauma, detecting brain cancer, and performing numerous other tests, magnetic resonance imaging (MRI) is the best option, but MRI scanners are costly, require special infrastructure, and are immobile.
NovaBay Pharmaceuticals, Inc. announced today that the latest public data on its Aganocide® compounds, a new class of broad-spectrum antimicrobials, will be presented during three poster sessions at the Association for Research in Vision and Ophthalmology annual meeting in Fort Lauderdale, Florida.
› Verified 9 days ago
Jeffrey Scheidlinger, Anesthesiology Medicare: Medicare Enrolled Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3138 | |
Jack A Stabile, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-689-3138 | |
Dr. Steven A Lussos, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3138 | |
Dr. Sabine E Duffy, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3138 Fax: 781-407-0998 | |
Dr. Roger A Denney, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3138 Fax: 540-982-2719 | |
Zhao Yang, M.D., PH.D Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3138 | |
Dr. Emma Alvaro Caligtan, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 201 North Washington Street, Falls Church, VA 22046 Phone: 703-237-4020 Fax: 703-536-1395 |